Revision of the Programme d’immunisation contre l’influenza au Québec

The last report issued by the Comité sur l’immunisation du Québec (CIQ) concerning the Programme d’immunisation contre l’influenza du Québec (PIIQ) [Québec’s Influenza Immunization program] was published in 2007. An update became necessary, given the many scientific advances that have occurred in this field.

The primary objective of the PIIQ must be to reduce influenza-associated hospitalizations and deaths.

To attain this objective, the CIQ recommends maintaining a…

Scientific advisory

Use of Live-Attenuated Influenza Virus Vaccine (LAIV), Flumist® in children and adolescents aged 2-17 years of age with chronic conditions

The live attenuated influenza virus vaccine (LAIV), Flumist®, administered by intranasal spray, is approved for people aged 2-59 years. The National Advisory Committee on Immunization (NACI) recommended in its statement for the 2011-2012 season that, given its efficacy and immunogenicity, LAIV should be used preferentially for healthy children and adolescents aged 2 to 17 years. NACI also indicates that LAIV can be used for children with chronic diseases, other than immune…

Scientific advisory

Public Health Ethics - Selected Resources: Ethics in a Pandemic

Public health ethics (PHE) is a relatively new field of study that encourages interdisciplinary discussion of moral issues related to the theory and practice of public health and preventive medicine. Emerging over the last 15 years out of dissatisfaction with the traditional orientations of biomedical ethics, PHE involves the explicit use of concepts from ethical, social and political theory to discuss and evaluate collective interventions that aim to protect and promote the health of…

Knowledge review